Follow
Brian M Bot
Brian M Bot
Fred Hutch Cancer Center
Verified email at fredhutch.org - Homepage
Title
Cited by
Cited by
Year
The consensus molecular subtypes of colorectal cancer
J Guinney, R Dienstmann, X Wang, A De Reynies, A Schlicker, ...
Nature medicine 21 (11), 1350-1356, 2015
45912015
The mPower study, Parkinson disease mobile data collected using ResearchKit
BM Bot, C Suver, EC Neto, M Kellen, A Klein, C Bare, M Doerr, A Pratap, ...
Scientific data 3 (1), 1-9, 2016
5752016
Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes
FA Sinicrope, Q Shi, TC Smyrk, SN Thibodeau, R Dienstmann, J Guinney, ...
Gastroenterology 148 (1), 88-99, 2015
3662015
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
R Dienstmann, MJ Mason, FA Sinicrope, AI Phipps, S Tejpar, ...
Annals of Oncology 28 (5), 1023-1031, 2017
2282017
Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients withá…
DJ Sargent, CH K÷hne, HK Sanoff, BM Bot, MT Seymour, A De Gramont, ...
Journal of Clinical Oncology 27 (12), 1948, 2009
2282009
Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing
Z Sun, YW Asmann, KR Kalari, B Bot, JE Eckel-Passow, TR Baker, ...
PloS one 6 (2), e17490, 2011
1882011
Tumor growth rate is an early indicator of antitumor drug activity in phase I clinical trials
C FertÚ, M Fernandez, A Hollebecque, S Koscielny, A Levy, C Massard, ...
Clinical Cancer Research 20 (1), 246-252, 2014
1802014
Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with opená…
J Guinney, T Wang, TD Laajala, KK Winner, JC Bare, EC Neto, SA Khan, ...
The Lancet Oncology 18 (1), 132-142, 2017
1612017
Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumors
R Dienstmann, IS Jang, B Bot, S Friend, J Guinney
Cancer discovery 5 (2), 118-123, 2015
1352015
Mobile health: the power of wearables, sensors, and apps to transform clinical trials
B Munos, PC Baker, BM Bot, M Crouthamel, G de Vries, I Ferguson, ...
Annals of the New York Academy of Sciences 1375 (1), 3-18, 2016
1292016
Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecaná…
D Sargent, Q Shi, G Yothers, E Van Cutsem, J Cassidy, L Saltz, ...
European journal of cancer 47 (7), 990-996, 2011
1082011
Remote smartphone monitoring of Parkinson’s disease and individual response to therapy
L Omberg, E Chaibub Neto, TM Perumal, A Pratap, A Tediarjo, J Adams, ...
Nature biotechnology 40 (4), 480-487, 2022
922022
Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from nine first-line phase III chemotherapy trials
CD Blanke, BM Bot, DM Thomas, A Bleyer, CH Kohne, MT Seymour, ...
Journal of clinical oncology 29 (20), 2781, 2011
832011
Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancerá…
A De Gramont, J Hubbard, Q Shi, MJ O'Connell, M Buyse, J Benedetti, ...
Journal of clinical oncology 28 (3), 460, 2010
782010
Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes
TH Ho, DJ Serie, M Parasramka, JC Cheville, BM Bot, W Tan, L Wang, ...
Annals of Oncology 28 (3), 604-610, 2017
772017
A large dataset of protein dynamics in the mammalian heart proteome
E Lau, Q Cao, D Ng, BJ Bleakley, TU Dincer, BM Bot, D Wang, DA Liem, ...
Scientific data 3 (1), 1-15, 2016
772016
Comparison of outcomes after fluorouracil-based adjuvant therapy for stages II and III colon cancer between 1978 to 1995 and 1996 to 2007: evidence of stage migration from theá…
Q Shi, T Andre, A Grothey, G Yothers, SR Hamilton, BM Bot, DG Haller, ...
Journal of clinical oncology 31 (29), 3656, 2013
742013
The Mole Mapper Study, mobile phone skin imaging and melanoma risk data collected using ResearchKit
DE Webster, C Suver, M Doerr, E Mounts, L Domenico, T Petrie, ...
Scientific data 4 (1), 1-8, 2017
692017
Detecting the impact of subject characteristics on machine learning-based diagnostic applications
E Chaibub Neto, A Pratap, TM Perumal, M Tummalacherla, P Snyder, ...
NPJ digital medicine 2 (1), 99, 2019
662019
Formative evaluation of participant experience with mobile eConsent in the app-mediated Parkinson mPower study: a mixed methods study
M Doerr, AM Truong, BM Bot, J Wilbanks, C Suver, LM Mangravite
JMIR mHealth and uHealth 5 (2), e6521, 2017
652017
The system can't perform the operation now. Try again later.
Articles 1–20